Close Menu

This story has been corrected to note that a single arm of a Brazilian hydroxychloroquine trial was ended over cardiotoxicity concerns but that the rest of the trial has continued. We regret the error.

NEW YORK – An international consortium of researchers has used protein interaction studies to identify antiviral agents that could be effective against SARS-CoV-2.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Russia says its candidate SARS-CoV-2 vaccine has a very high efficacy rate in an initial analysis of clinical trial data, according to the Financial Times.

Wired reports on a microbial analysis of sketches drawn by Leonardo DaVinci.

A new survey explores coronavirus vaccine hesitancy among Black and Latino individuals, the Washington Post reports.

In Nucleic Acids Research this week: the Aging Atlas database, a database of human metagenome-related metadata, and more.